Business

F.D.A. Approves the Drug Daraxonrasib That’sPoised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Read full story on The New York Times →

Gina Kolata, Rebecca Robbins and Carolyn Y. Johnson27 Aug 2026, 01:58 pmUpdated 6h ago1 min readBusinessGlobal

Global — Gina Kolata, Rebecca Robbins and Carolyn Y. Johnson

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

This report is published with credit to The New York Times. The wire sent a summary; open the original for any extra context. Read on The New York Times →

Source: The New York Times · Gina Kolata, Rebecca Robbins and Carolyn Y. Johnson. Published 27 Aug 2026, 01:58 pm.

Next news → Gaana, Fenix360 to create direct artist-fa…Browse more stories

Keep reading

Most relevant

Gaana, Fenix360 to create direct artist-fan system

Read on Economic Times →

Editor’s choice

How SSENSE, a Canadian Retailer, Is Grappling With Trump’s Tariffs

Ssense’s comeback efforts include moving a core part of its business to the United States so American customers can avoid hefty tariffs.

Read on The New York Times →

Also developing

In Graphics: Kitchen basket inflation is back

Read on Economic Times →

Back to the desk

info@ebenezerdigital.com +91 98944 96560 WhatsApp